Schizophrenia trials in Austria
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStratification and Treatment in Early Psychosis Study - ENHANCE
- Where
- Vienna
- Age
- 16 years to 40 years
- People
- 250 worldwide
- Run by
- University of Oxford
See details and how to joinNCT06778564 · EU 2025-521929-32-00 - Phase 3Not yet taking people in AustriaStratification and Treatment in Early Psychosis Study - PROMOTE
- Where
- Vienna
- Age
- 12 years to 35 years
- People
- 586 worldwide
- Run by
- University of Oxford
See details and how to joinNCT07434973 - No phaseTaking peopleUnderstanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia
- Where
- Innsbruck
- Age
- 18 years to 70 years
- People
- 180
- Run by
- Medical University Innsbruck
See details and how to joinNCT07856381 - Phase 4Taking peopleAn open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need of adjustment of oral antipsychotic treatment
- Where
- Innsbruck, Salzburg
- Age
- 18 years and over
- People
- 20
- Run by
- Medizinische Universitaet Innsbruck
See details and how to join2024-518042-24-00 · EU 2024-518042-24-00 - No phaseNot yet taking people in AustriaPersonalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
- Where
- Vienna
- Age
- 18 years to 65 years
- People
- 140 worldwide
- Run by
- Ludwig-Maximilians - University of Munich
See details and how to joinNCT07586150 - No phaseNot yet taking people in AustriaDopamine and Insulin in Psychosis
- Where
- Vienna
- Age
- 18 years to 40 years
- People
- 46
- Run by
- Medical University of Vienna
See details and how to joinNCT07252752 - Phase 4Taking peopleThe Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
- Where
- Innsbruck
- Age
- 18 years to 70 years
- People
- 418 worldwide
- Run by
- Dr. Inge Winter
See details and how to joinNCT05958875 · EU 2023-506602-39-00 - Phase 3Taking peopleKetamine study
- Where
- Vienna
- Age
- 18 years to 64 years
- People
- 20
- Run by
- Medical University Of Vienna
See details and how to join2024-519097-39-01 · EU 2024-519097-39-01